Safety and efficacy of single pass vs multipass emission with 755 alexandrite laser for all-skin-type hair removal: A pilot study.

Abstract:

:Lasers are considered the most efficient methods for hair reduction. The goal of these devices is to provide long-term effects without adverse reactions. This is a randomized split-body controlled study on body hair removal and pseudofolliculitis (PFC) treatment, comparing the standard single pass (SP) emission with the multipass emission (Moveo handpiece) with 755 alexandrite laser. Patients with Fitzpatrick skin types I to VI underwent laser hair removal, by treating one side of the body using the standard SP and the other side with Moveo. Treated areas included face, arms, legs, trunk, axillae and groins. Each patient underwent a minimum of three to a maximum of eight treatments, every 6 weeks, with a 6-month follow-up. Hair reduction, side effects, PFC severity score and patient satisfaction were recorded for all patients. Totally, 108 patients were enrolled, of whom 96 were female. The overall hair reduction rate (% ± SD), independent of skin type, was estimated as 87 ± 5.5 for standard SP and 78.5 ± 7.6 for Moveo. No significant statistically differences were found between the two groups. Side effects included pain, which was higher after standard SP (4.2 ± 0.8) than after Moveo treatment (1.5 ± 0.5). A statistical significant difference between the two devices was found (P = .0002). PFC score improved in almost all the patients. Patients declared to be satisfied with both the treatments, reporting a preference for Moveo (84% vs 16%) (P = .01). Standard SP and Moveo 755 alexandrite laser seems to be safe and effective treatments for hair removal in all Fitzpatrick skin types and for PFC. Moveo has a higher security profile with fewer side effects.

journal_name

Dermatol Ther

journal_title

Dermatologic therapy

authors

Bonan P,Troiano M,Verdelli A

doi

10.1111/dth.14001

subject

Has Abstract

pub_date

2020-11-01 00:00:00

pages

e14001

issue

6

eissn

1396-0296

issn

1529-8019

journal_volume

33

pub_type

杂志文章
  • Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.

    abstract::Non-peristomal postoperative pyoderma gangrenosum (PPG) is a rare subtype of pyoderma gangrenosum that occurs in the early postoperative period at surgical incisions, most commonly after breast surgery. Early diagnosis and treatment is essential to prevent severe scaring. TNF-alpha inhibitor infliximab was reported to...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.12774

    authors: Ariane M,Bouaziz JD,de Masson A,Jachiet M,Bagot M,Lepelletier C

    更新日期:2019-01-01 00:00:00

  • Therapeutic hotline. Effectiveness of the association of cetirizine and topical steroids in lichen planus pilaris--an open-label clinical trial.

    abstract::Lichen planus is considered a T cell-mediated immunological disease. Even mast cells may contribute to the pathogenesis of the disease. Keratinocytes of the basal layer of the skin and/or the hair follicle may represent the "target/victim" of an immune aggression, determining the destruction of the hair follicle and t...

    journal_title:Dermatologic therapy

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1529-8019.2010.01359.x

    authors: d'Ovidio R,Rossi A,Di Prima TM

    更新日期:2010-09-01 00:00:00

  • New and emerging biologic therapies for moderate-to-severe plaque psoriasis: mechanistic rationales and recent clinical data for IL-17 and IL-23 inhibitors.

    abstract::The development of effective and well-tolerated biologic therapies has advanced the management of psoriasis by enabling clinicians to treat underlying disease mechanisms. Biologics approved for the treatment of moderate-to-severe psoriasis include three tumor necrosis factor alpha inhibitors and an interleukin-12/inte...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12251

    authors: Gaspari AA,Tyring S

    更新日期:2015-07-01 00:00:00

  • Diagnosis and treatment of cutaneous paraneoplastic disorders.

    abstract::The skin plays a critical role in the detection of internal malignances. Cutaneous signs of these disorders afford clinicians opportunities for early diagnosis and treatment. We aim to succinctly review the recognition, diagnosis, and treatment of selected cutaneous paraneoplastic diseases. Skin disorders that may be ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2010.01371.x

    authors: Abreu Velez AM,Howard MS

    更新日期:2010-11-01 00:00:00

  • Breaking paradigms in the treatment of psoriasis: Use of botulinum toxin for the treatment of plaque psoriasis.

    abstract::Some studies have demonstrated that neurotransmitters are involved in the pathogenesis of numerous skin conditions, including psoriasis, addressing the close correlation between the skin and the central nervous system. There are reports showing psoriasis improvement after peripheral nervous system injury. In addition,...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14319

    authors: González C,Franco M,Londoño A,Valenzuela F

    更新日期:2020-11-01 00:00:00

  • Network pharmacology-based identification for therapeutic mechanisms of Dangguikushen pill in acne vulgaris.

    abstract::The Dangguikushen (DGKS) pill is a proprietary traditional Chinese medicine that has shown superior efficacy in the treatment of acne vulgaris for many years. A network pharmacology-based analysis was performed to explore the potential anti-acne compounds, core therapeutic targets, and the main pathways, involved in t...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14061

    authors: Yu B,Diao NN,Zhang Y,Li XZ,Yu N,Ding YF,Shi YL

    更新日期:2020-11-01 00:00:00

  • Management of chronic pruritus with a UV filtering topical cream.

    abstract::Chronic pruritus is a common dermatological condition affecting 10-13% of the general population. UVB phototherapy has been demonstrated to be effective in relieving the symptoms of pruritus. However, phototherapy is rarely administered because the treatment is time-consuming and expensive, when compared to other topi...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.12309

    authors: Zanardelli M,Kovacevic M,McCoy J,Wang X,Goren A,Lotti T

    更新日期:2016-03-01 00:00:00

  • Mechanism of Oleogel-S10: A triterpene preparation for the treatment of epidermolysis bullosa.

    abstract::Epidermolysis bullosa (EB) is a group of rare heterogeneous, genetic disorders. Currently, there is no effective pharmacological or genetic therapy for all EB subtypes. Dry extract from birch bark and betulin upregulate some pro-inflammatory mediators and downregulate others. The increase in pro-inflammatory cytokines...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12983

    authors: Schwieger-Briel A,Ott H,Kiritsi D,Laszczyk-Lauer M,Bodemer C

    更新日期:2019-07-01 00:00:00

  • The use of oral antibiotics in treating acne vulgaris: a new approach.

    abstract::Although acne is not an infectious disease, oral antibiotics have remained a mainstay of treatment over the last 40 years. The anti-inflammatory properties of oral antibiotics, particularly the tetracyclines, are efficacious in treating inflammatory acne lesions. Common prescribing practices in Dermatology exert signi...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.12370

    authors: Farrah G,Tan E

    更新日期:2016-09-01 00:00:00

  • Infection and panniculitis.

    abstract::Infection-induced panniculitis may result from a number of microbes including bacteria, fungi, and parasites. Viruses have also been implicated as a cause. This type of panniculitis can occur as a primary infection by direct inoculation of infectious microorganisms into the subcutaneous tissue, or secondarily via micr...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2010.01333.x

    authors: Morrison LK,Rapini R,Willison CB,Tyring S

    更新日期:2010-07-01 00:00:00

  • Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata.

    abstract::Alopecia areata (AA) is a common disease that results in nonscarring hair loss. Recently, tofacitinib (TOFA) has been a novel promising therapy for AA. The aim of this study is to determine the efficacy of oral TOFA treatment for alopecia areata (AA), and alopecia universalis (AU). Data of nine patients treated with o...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13118

    authors: Akdogan N,Ersoy-Evans S,Doğan S,Atakan N

    更新日期:2019-11-01 00:00:00

  • Intravenous antibiotics used in dermatology.

    abstract::It is not common for dermatologists to use intravenous antibiotics in daily practice. However, there are several serious infections that may come to the attention of a dermatologist because of cutaneous signs and symptoms. It is important for dermatologists to be familiar with the presenting symptoms, various stages o...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2012.01533.x

    authors: Sambrano B,Gordon R,Mays R,Lapolla W,Scheinfeld N

    更新日期:2012-01-01 00:00:00

  • Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.

    abstract::Pemphigus vulgaris (PV), an autoimmune blistering disease is treated with immunosuppressive medications. As the immunosuppressive effect of rituximab, the first-line therapy of PV, lasts more than 6 months, many concerns have raised due to the ongoing novel coronavirus disease (COVID-19) pandemic. With this background...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.14405

    authors: Beyzaee AM,Rahmatpour Rokni G,Patil A,Goldust M

    更新日期:2020-10-13 00:00:00

  • A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg.

    abstract::A change of pricing policy in Spain have made both doses of ustekinumab (UST), 45 and 90 mg, recently available at the same price. Our primary objective was to evaluate effectiveness of UST 90 mg at 52 and 104 weeks in psoriasis patients in clinical practice; secondary objectives were to study the reasons for using th...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13678

    authors: Llamas-Velasco M,Baniandrés O,Rivera R,Reymundo Jimenez A,Hospital M,García Zamora E,González-Cantero Á,Andrés Lencina JJ,Daudén E,de la Cueva P

    更新日期:2020-07-01 00:00:00

  • Case report: A successful combined treatment of severe lupus miliaris disseminatus faciei with oral isotretinoin and methylprednisolone.

    abstract::Lupus miliaris disseminates faciei (LMDF) is a rare inflammatory dermatosis characterized by an asymptomatic papular eruption in the central face, of which the etiology and pathogenesis are not clear. There is a lack of standard treatment recommendations, especially for severe cases. Here we report a new case of succe...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13267

    authors: Yin S,Sun L

    更新日期:2020-03-01 00:00:00

  • Fractional carbon dioxide laser-assisted delivery of lyophilized-growth factors is a promising treatment modality of post-acne scars.

    abstract::Lyophilized-growth factors (L-GFs), is a new platelet rich plasma (PRP) preparation that is standardized in growth factors concentrations. The aim of this study was to compare the therapeutic efficacy of ablative fractional CO2 laser in combination with L-GFs vs PRP in post-acne scars. This study was conducted on 45 p...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14488

    authors: Neinaa YME,Al-Khayat LA,Suliman GAM,Ameen TE

    更新日期:2020-11-01 00:00:00

  • Laser tattoo removal: Fundamental principles and practical approach.

    abstract::Tattoos have long become a part of human civilization. However, as the number of people who get tattoos increases, so is the number of people who wish to have their tattoos removed. Compared to other methods, laser-based devices are associated with the best efficacy and least side effects in tattoo removal. Lack of un...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.14418

    authors: Kurniadi I,Tabri F,Madjid A,Anwar AI,Widita W

    更新日期:2020-10-17 00:00:00

  • Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study.

    abstract::Pustulosis palmoplantaris (PPP; synonyms: pustulosis palmaris et plantaris, palmoplantar amicrobic pustulosis) is a common chronic, relapsing, pustular eruption affecting the palms and soles. The authors report the successful treatment of six therapy-experienced patients with histologically confirmed PPP with oral itr...

    journal_title:Dermatologic therapy

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1529-8019.2008.01219.x

    authors: V'lckova-Laskoska MT,Caca-Biljanovska NG,Laskoski DS,Kamberova SJ

    更新日期:2009-01-01 00:00:00

  • Challenges of COVID-19 pandemic for dermatology.

    abstract::Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new coronavirus responsible for the pandemic named coronavirus disease 2019 (COVID-19). The disease causes SARS with a significant morbidity and mortality. We provide a review with a focus on COVID-19 in dermatology. We discuss triage of suspected infec...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13430

    authors: Wollina U

    更新日期:2020-09-01 00:00:00

  • Unsatisfactory response to sirolimus in Maffucci syndrome-associated spindle cell hemangiomas.

    abstract::Maffucci syndrome is characterized by multiple benign vascular anomalies and enchondromas present on the distal extremities. Effective treatment options are currently not available for Maffucci syndrome-associated vascular lesions. Sirolimus is a mTOR pathway inhibitor, and has been tried successfully in the treatment...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.12851

    authors: Gupta V,Mridha AR,Khaitan BK

    更新日期:2019-05-01 00:00:00

  • Intralesional sclerotherapy for the treatment of acne cysts: A case series.

    abstract::Acne cysts are a common dermatological problem that often leads to scarring and a significant negative impact on patients' psyche. The aim of the study was to evaluate the usefulness of intralesional foam sclerotherapy for the treatment of cystic acne. Patients with cystic acne treated with intralesional foam scleroth...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13505

    authors: Bhattacharjee R,Kumar S,Vinay K,Narang T,Dogra S

    更新日期:2020-11-01 00:00:00

  • Juvenile psoriatic arthritis and comorbidities: report of a case associated with enthesitis and celiac disease.

    abstract::The present authors report the case of a 9-year-old boy affected by psoriasis, juvenile psoriatic arthritis, enthesitis, and celiac disease. The signs and symptoms of the different comorbidities appeared at different times in the clinical history, complicating the overall diagnostic and therapeutic procedures. Coopera...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2010.01301.x

    authors: Prignano F,Bonciani D,Bandinelli F,Matucci Cerinic M,Lotti T

    更新日期:2010-03-01 00:00:00

  • Comparative histological and immunohistochemical changes in recurrent nodular basal cell carcinoma after photodynamic therapy.

    abstract::Photodynamic therapy (PDT) is an established nonsurgical treatment for nodular basal cell carcinoma (nBCC). This study compares the clinical, histopathological, and immunohistochemical findings in recurrent nBCC after PDT versus pre-treatment (primary) nBCC. This retrospective study analyzed nodular BCCs treated with ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.14779

    authors: Gracia-Cazaña T,Nicolás J,Cerro-Muñoz PA,González S,Juarranz Á,Gilaberte Y

    更新日期:2021-01-13 00:00:00

  • Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite fillers.

    abstract::Soft-tissue augmentation with hyaluronic acid and calcium hydroxyl apatite are among the most widely used minimally invasive cosmetic treatments for the correction of contour deficiencies and wrinkles of the face without the risk, recovery time, and expense of a major surgery. Training and experience in the art and sc...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/j.1529-8019.2010.01380.x

    authors: Redbord KP,Busso M,Hanke CW

    更新日期:2011-01-01 00:00:00

  • Clinical, etiopathogenic, and therapeutic aspects of KID syndrome.

    abstract::Keratitis-ichthyosis-deafness (KID syndrome) is a syndromes ichthyoses that is clinically and genetically heterogeneous requiring early and long-term multidisciplinary monitoring of affected individuals. A review of the clinical, etiopathogenic and therapeutic aspects is presented of this rare congenital ectodermal di...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13507

    authors: Cammarata-Scalisi F,Willoughby CE,Cárdenas Tadich A,Labrador N,Herrera A,Callea M

    更新日期:2020-07-01 00:00:00

  • Eccrine porocarcinoma.

    abstract::Eccrine porocarcinoma (EPC) is a rare cutaneous neoplasm that grows slowly over a long period of time but often experiences an accelerated growth phase. This malignant tumor may arise denovo or evolve from a pre-existing benign eccrine poroma. Histologic evaluation demonstrates anaplastic cells involving the epidermis...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/j.1529-8019.2008.00243.x

    authors: Brown CW Jr,Dy LC

    更新日期:2008-11-01 00:00:00

  • Omalizumab in children and adolescents with chronic spontaneous urticaria: Case series and review of the literature.

    abstract::The recent EAACI/GA2 LEN/EDF/WAO guidelines recommend omalizumab (anti-IgE) for the management of patients aged ≥12 years with chronic urticaria unresponsive to high-doses second-generation H1 -antihistamines (antiH1 ). However, there is little published information on the success of omalizumab for such a treatment in...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13489

    authors: Passanisi S,Arasi S,Caminiti L,Crisafulli G,Salzano G,Pajno GB

    更新日期:2020-07-01 00:00:00

  • Can serum level of N-terminal pro B-type natriuretic peptide be used in patients with psoriasis as a predictor of cardiovascular disease?

    abstract::Past studies have reported associations between psoriasis, metabolic syndrome, and atherosclerotic cardiovascular disease. According to studies, N-terminal pro B-type natriuretic peptide (NT-proBNP) is a useful screening test for cardiac disease. We examined the serum NT-proBNP level in patients with psoriasis and com...

    journal_title:Dermatologic therapy

    pub_type: 信件

    doi:10.1111/dth.12865

    authors: Shahidi-Dadras M,Niknezhad N,Niknejad N,Zargari O

    更新日期:2019-05-01 00:00:00

  • Comparative evaluation of therapeutic efficacy and safety of intralesional triamcinolone acetonide injection vs intralesional radiofrequency with intralesional triamcinolone acetonide in treatment of keloids.

    abstract::Management of keloid is difficult, so there is always a need for adequate and effective therapy. In this study, we explored and compared the efficacy and synergistic effect of combined intralesional radiofrequency (RF) and intralesional triamcinolone acetonide (TAC) with intralesional triamcinolone acetonide alone in ...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章

    doi:10.1111/dth.13919

    authors: Kaushal V,Kumar S,Brar BK,Singh A

    更新日期:2020-11-01 00:00:00

  • Coronavirus disease (COVID-19): An updated review based on current knowledge and existing literature for dermatologists.

    abstract::The world entered the year 2020 with reports of the emergence of a new viral illness in Wuhan city, Hubei province, China. In January 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified to be the causative novel coronavirus for the cluster of patients suffering from pneumonia in China. Th...

    journal_title:Dermatologic therapy

    pub_type: 杂志文章,评审

    doi:10.1111/dth.13677

    authors: Kaur I,Sharma A,Jakhar D,Das A,Aradhya SS,Sharma R,Jindal V,Mhatre M

    更新日期:2020-07-01 00:00:00